NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3077% above fair value

$12.02−0.50 (-3.99%)

Close on Nov 12, 2026Market cap $412.58MP/E –Yield 0.00%

NeuroPace EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

NeuroPace's EPS for the twelve months ending Sep 30, 2026 was -$0.56. For fiscal 2025 it was -$0.66. The highest annual figure on record is -$0.66 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.66	–
FY2024	Dec 31, 2024	-$0.93	–
FY2023	Dec 31, 2023	-$1.27	–
FY2022	Dec 31, 2022	-$1.91	–
FY2021	Dec 31, 2021	-$2.17	–
FY2020	Dec 31, 2020	-$117.85	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.10	–
Q2 FY2026	Jun 30, 2026	-$0.18	–
Q1 FY2026	Mar 31, 2026	-$0.20	–
Q4 FY2025	Dec 31, 2025	-$0.08	–
Q3 FY2025	Sep 30, 2025	-$0.11	–
Q2 FY2025	Jun 30, 2025	-$0.26	–
Q1 FY2025	Mar 31, 2025	-$0.21	–
Q4 FY2024	Dec 31, 2024	-$0.18	–
Q3 FY2024	Sep 30, 2024	-$0.19	–
Q2 FY2024	Jun 30, 2024	-$0.26	–
Q1 FY2024	Mar 31, 2024	-$0.32	–
Q4 FY2023	Dec 31, 2023	-$0.23	–
Q3 FY2023	Sep 30, 2023	-$0.28	–
Q2 FY2023	Jun 30, 2023	-$0.36	–
Q1 FY2023	Mar 31, 2023	-$0.41	–
Q4 FY2022	Dec 31, 2022	-$0.45	–
Q3 FY2022	Sep 30, 2022	-$0.48	–
Q2 FY2022	Jun 30, 2022	-$0.52	–
Q1 FY2022	Mar 31, 2022	-$0.47	–
Q3 FY2021	Sep 30, 2021	-$0.34	–
Q2 FY2021	Jun 30, 2021	-$0.48	–
Q1 FY2021	Mar 31, 2021	-$32.73	–
Q4 FY2020	Dec 31, 2020	-$22.08	–
Q3 FY2020	Sep 30, 2020	-$19.26	–
Q2 FY2020	Jun 30, 2020	-$43.44	–
Q1 FY2020	Mar 31, 2020	-$33.32	–